English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Generation of an iPSC line of a patient with Angelman syndrome due to an imprinting defect

MPS-Authors
/persons/resource/persons232003

Brändl,  Björn
Dept. of Genome Regulation (Head: Alexander Meissner), Max Planck Institute for Molecular Genetics, Max Planck Society;

/persons/resource/persons220217

Müller,  Franz-Josef
Cellular Phenotyping (Franz-Josef Müller), Dept. of Genome Regulation, (Head: Alexander Meissner), Max Planck Institute for Molecular Genetics, Max Planck Society;

External Resource
No external resources are shared
Fulltext (public)

Neureiter.pdf
(Publisher version), 972KB

Supplementary Material (public)
There is no public supplementary material available
Citation

Neureiter, A., Brändl, B., Hiber, M., Tandon, R., Müller, F.-J., & Steenpass, L. (2018). Generation of an iPSC line of a patient with Angelman syndrome due to an imprinting defect. Stem Cell Research, 33, 20-24. doi:10.1016/j.scr.2018.09.015.


Cite as: http://hdl.handle.net/21.11116/0000-0003-8DE1-0
Abstract
Angelman syndrome (AS) is a neurodevelopmental disorder with leading symptoms of happy demeanor, intellectual disability, ataxia and seizures. AS can be caused by genetic and epigenetic aberrations, resulting in the absence of functional UBE3A protein in the brain. UBE3A is an imprinted gene, which is, in neurons of the brain, expressed exclusively from maternal chromosome 15. The generated iPSC line was derived from skin fibroblasts of a patient with AS, who, due to an imprinting defect, lacked DNA methylation at the chromosome 15 imprinting center, which controls maternal-specific expression of UBE3A. Resource table.